Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women.
Qasim. Mustafa M; Ricks-Santi. Luisel J LJ; Naab. Tammey J TJ; Rajack. Fareed F; Beyene. Desta D; Abbas. Muneer M; Kassim. Olakunle O OO; Copeland. Robert L RL; Kanaan. Yasmine Y
Key Findings
- KISS1 protein levels are higher in triple‑negative breast cancer (TNBC) compared to other subtypes.
- KISS1R receptor levels are lower in TNBC and higher in non‑TNBC tumors.
- There is a significant inverse correlation between KISS1 and KISS1R expression in TNBC.
Practical Outcomes
- The findings are mainly of scientific interest and don’t translate into actionable protocols for longevity or performance. For now, they simply highlight a potential future target for cancer therapy, not something biohackers can safely experiment with.
Summary
Researchers looked at two proteins, kisspeptin (KISS1) and its receptor (KISS1R), in breast tumors from African American women. They found that the cancer‑blocking protein KISS1 was higher in the aggressive triple‑negative type, while its receptor was lower, showing an opposite pattern. This suggests the kisspeptin system might play a role in how these cancers develop, but the study doesn’t give any direct advice for health‑hacking or everyday use.
Abstract
The kisspeptin 1 (KISS1) gene encodes a precursor polypeptide which after proteolysis forms the kisspeptin-10 (KISS1) protein. KISS1, retains maximum physiological activity when it binds to its receptor (KISS1R), allowing KISS1 to effectively function as a suppressor of metastasis in melanomas and other types of cancer. The goal of this study was to evaluate the expression of KISS1 and KISS1R in breast carcinomas from African American (AA) women and correlate their association with clinicopathological features, including breast cancer subtypes, and outcomes. Tissue microarrays were constructed from formalin-fixed, paraffin-embedded surgical blocks from 216 AA patients. KISS1 and KISS1R expression was assessed using immunohistochemistry. Univariate analysis was used to determine the association between the expression of KISS1 and KISS1R, and clinicopathological characteristics. Pearson correlation was also determined between immunohistochemical H-scores, tumor size, and the number of positive lymph nodes. Kaplan-Meier estimates of overall and disease-free survival were plotted, and log-rank tests were performed to compare estimates among groups. KISS1 protein expression was found to be higher in receptor-negative and triple-negative breast cancer (TNBC) compared to other subtypes (p<0.001). However, KISS1R expression was higher in non-TNBC tumors compared to other subtypes (p<0.001). Higher KISS1R expression was marginally negatively correlated with tumor size (p=0.077), and positively correlated with lymph-node positivity (p=0.056), and disease-free survival (p=0.092). Our study showed a significant inverse correlation between KISS1 and KISS1R in TNBC. This investigation implicates a role for KISS1 and KISS1R in the pathogenesis of TNBCs in AA women.
Study Information
pubmed
2022
10.21873/cgp.20350
1
43